NantHealth - NH Stock Forecast, Price & News

NantHealth's stock was trading at $3.65 at the beginning of the year. Since then, NH shares have decreased by 48.7% and is now trading at $1.8735.
View the best growth stocks for 2023 here.

NantHealth saw a increase in short interest in February. As of February 28th, there was short interest totaling 51,000 shares, an increase of 17.5% from the February 13th total of 43,400 shares. Based on an average trading volume of 104,100 shares, the short-interest ratio is currently 0.5 days. Currently, 2.0% of the company's stock are short sold.
View NantHealth's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our NH earnings forecast.

NantHealth, Inc. (NASDAQ:NH) released its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The business earned $14.36 million during the quarter, compared to analysts' expectations of $17.70 million. During the same period in the prior year, the company posted ($0.08) EPS.

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

NantHealth trades on the NASDAQ under the ticker symbol "NH."

NantHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Millennium Management LLC (0.13%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends.

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NH stock can currently be purchased for approximately $1.87.

NantHealth (NASDAQ:NH) has a market capitalization of $14.44 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis.

The company employs 326 workers across the globe.

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.